A comprehensive and detailed study of the current and probable future market for patient self-monitoring products, technology and participants, this report identifies, evaluates and forecasts the impact of demographic and technology factors on this significant worldwide market.  The ability of patients to monitor their own blood serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring is now performed in physician offices or similar healthcare settings. But this will change. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market by the end of the decade. The report describes how the convergence of new measurement technologies, patient demographics and managed care cost initiatives will drive patient self-monitoring from caregiver facilities and into homes, transforming patient self-monitoring into a significant market by the end of the decade.

Publication Date: February 2006